Crohn's Disease
Prevalence: ~0.3% in Western countries; peak onset 15-35 years
Evidence-Ranked Ingredients
| Ingredient | Grade | Studies | Direction | |
|---|---|---|---|---|
| Omega-3 Fatty Acids (EPA/DHA) | C | 6 | Mixed | View → |
| L-Glutamine | C | 3 | Positive | View → |
| Curcumin | C | 3 | Mixed | View → |
| Butyrate (Sodium/Calcium Butyrate) | C | 2 | Positive | View → |
About
A chronic inflammatory bowel disease that can affect any part of the GI tract from mouth to anus, most commonly the terminal ileum and colon. Features transmural inflammation with skip lesions, granulomas, and potential complications including strictures, fistulae, and abscesses.
Common Symptoms
Risk Factors
- Smoking (strongest modifiable risk)
- Genetics (NOD2/CARD15)
- Western diet
- Antibiotic exposure
- Family history
Frequently Asked Questions
What supplements are studied for Crohn's Disease?
How is the evidence for Crohn's Disease supplements graded?
How many studies on Crohn's Disease supplements have been reviewed?
What are common symptoms of Crohn's Disease?
Related Conditions
Conditions that share studied ingredients
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.